June 27, 2011 — Researchers may have discovered one reason that African-Americans are at increased risk for heart attacks and other cardiovascular events.

According to a new study published online in the journal Radiology, African-Americans have increased levels of non-calcified plaque, which consists of buildups of soft deposits deep in the walls of the arteries that are not detected by some cardiac tests. Non-calcified plaque is more vulnerable to rupturing and causing a blood clot, which could lead to a heart attack or other cardiovascular event.

According to the U.S. Department of Health and Human Services, African-American adults are more likely to be diagnosed with coronary heart disease and are at greater risk of death from heart disease than white adults. In 2007, African-American men were 30 percent more likely than non-Hispanic white men to die from heart disease.

“For a long time, physicians have searched for explanations as to why African-Americans have higher rates of heart disease and higher cardiac death rates, but less coronary artery calcium than Caucasians,” said U. Joseph Schoepf, M.D., professor of radiology and medicine and director of cardiovascular imaging at Medical University of South Carolina in Charleston. “We show that one possible explanation for the discrepancy may be found in the higher rate of less stable, non-calcified plaque in the heart vessels of African-Americans.”

Calcium scoring with computed tomography (CT) is a common screening tool for patients at risk for cardiovascular disease because increased levels of calcified plaque in the coronary arteries generally links to a greater risk of heart attack or other cardiovascular event. However, calcium scoring does not detect non-calcified plaque.

For the study, researchers compared 301 patients who underwent both calcium scoring with CT and contrast-enhanced coronary CT angiography (cCTA). cCTA provides a more comprehensive picture of the arteries, including the presence of non-calcified and mixed plaques.

The study group comprised 50 percent each of African-American and white patients, 33 percent of whom were male (mean age 55).

Calcium scoring revealed that calcified plaque was much more prevalent in the coronary arteries of white patients than in African-Americans (45 percent versus 26 percent). The cCTA revealed that, compared with the white patients, many more African-American patients had non-calcified plaque (64 percent versus 41 percent), and in greater amounts. The median volume of non-calcified plaque among the African-American patients was 2.2 milliliters (mL), compared with 1.4 mL among white patients.

Based on these results, the researchers suggest that the value of calcium scoring as a screening tool for African-Americans should be reexamined.

“The results of coronary artery calcium scoring studies are to be treated with caution in African-Americans, because they may not reflect the true extent of cardiovascular disease,” Dr. Schoepf said.

While cCTA does expose patients to ionizing radiation, according to Dr. Schoepf, the effective dose of this procedure has been considerably reduced over the past few years, making it a viable screening option if other prerequisites of a successful screening test are also met.

“For African-American patients, coronary CT angiography may be a more appropriate screening tool for cardiovascular risk,” he said.

For more information: http://radiology.rsna.org/


Related Content

News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Enterprise Imaging

April 25, 2024 — International medical imaging IT and cybersecurity company Sectra has signed two contracts to provide ...

Time April 25, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
Subscribe Now